Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Expert Review of Anti-Infective Therapy

• Publication date

  2006-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1586/14787210.4.5.795PMID 17140356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.

  2007cited by this paper
• Increased antiviral medication sales before the 2005-06 influenza season--New York City.

  2006cited by this paper
• Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.

  2006cited by this paper
• Amantadine Resistance among Porcine H1N1, H1N2, and H3N2 Influenza A Viruses Isolated in Germany between 1981 and 2001

  2006cited by this paper
• Neuraminidase Inhibitor-Resistant and -Sensitive Influenza B Viruses Isolated from an Untreated Human Patient

  2006cited by this paper
• Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.

  2006cited by this paper
• Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.

  2006cited by this paper
• Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.

  2006cited by this paper
• Antiviral resistance in influenza viruses--implications for management and pandemic response.

  2006cited by this paper
• The M2 Proton Channels of Influenza A and B Viruses*

  2006cited by this paper
• Oseltamivir resistance during treatment of influenza A (H5N1) infection.

  2005cited by this paper
• Generation and Characterization of Recombinant Influenza A (H1N1) Viruses Harboring Amantadine Resistance Mutations

  2005cited by this paper
• Mechanism of Action of T-705 against Influenza Virus

  2005cited by this paper
• Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

  2005cited by this paper
• Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors

  2005cited by this paper
• Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations.

  2005cited by this paper
• Neuraminidase Inhibitor-Resistant Influenza Viruses May Differ Substantially in Fitness and Transmissibility

  2005cited by this paper
• Neuraminidase inhibitors for influenza.

  2005cited by this paper
• Use of influenza antivirals during 2003-2004 and monitoring of neuraminidase inhibitor resistance.

  2005cited by this paper
• Avian flu: Isolation of drug-resistant H5N1 virus

  2005cited by this paper
• Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.

  2005cited by this paper
• Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern.

  2005cited by this paper
• [Anti-virals for influenza virus infection].

  2005cited by this paper
• Potential Impact of Antiviral Drug Use during Influenza Pandemic

  2005cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir: descriptive study.

  2004cited by this paper
• Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP)

  2004cited by this paper
• Characterization of influenza A and B viruses recovered from immunocompromised patients treated with antivirals

  2004cited by this paper
• Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.

  2004cited by this paper
• Emergence and Transmission of Amantadine‐Resistant Influenza A in a Nursing Home

  2004cited by this paper
• Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.

  2004cited by this paper
• Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors.

  2004cited by this paper
• Re-emergence of fatal human influenza A subtype H5N1 disease

  2004cited by this paper
• Inhibition of influenza virus production in virus-infected mice by RNA interference.

  2004cited by this paper
• Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir

  2003cited by this paper
• Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.

  2003cited by this paper
• Evaluation of Neuraminidase Enzyme Assays Using Different Substrates To Measure Susceptibility of Influenza Virus Clinical Isolates to Neuraminidase Inhibitors: Report of the Neuraminidase Inhibitor Susceptibility Network

  2003cited by this paper
• Frequency of Amantadine-Resistant Influenza A Viruses during Two Seasons Featuring Cocirculation of H1N1 and H3N2

  2003cited by this paper
• Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient.

  2003cited by this paper
• High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza.

  2003cited by this paper
• The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines.

  2003cited by this paper
• Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza

  2002cited by this paper
• Detection of Amantadine-Resistant Influenza A Virus Strains in Nursing Homes by PCR-Restriction Fragment Length Polymorphism Analysis with Nasopharyngeal Swabs

  2002cited by this paper
• The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

  2002cited by this paper
• Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir

  2002cited by this paper
• Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets.

  2002cited by this paper
• In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication

  2002cited by this paper
• Updating the Accounts: Global Mortality of the 1918-1920 "Spanish" Influenza Pandemic

  2002cited by this paper
• Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo.

  2002cited by this paper
• Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.

  2001cited by this paper
• Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses

  2001cited by this paper
• Oral oseltamivir treatment of influenza in children

  2001cited by this paper
• Developing vaccines against pandemic influenza.

  2001cited by this paper
• Position statement: global neuraminidase inhibitor susceptibility network.

  2001cited by this paper
• Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease

  2000cited by this paper
• Resistance of influenza viruses to neuraminidase inhibitors--a review.

  2000cited by this paper
• In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir.

  1999cited by this paper
• Low incidence of rimantadine resistance in field isolates of influenza A viruses.

  1999cited by this paper
• Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802

  1999cited by this paper
• Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors

  1998cited by this paper
• Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071

  1998cited by this paper
• Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus.

  1998cited by this paper
• The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en.

  1998cited by this paper
• The impact of influenza epidemics on mortality: introducing a severity index.

  1997cited by this paper
• Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en

  1997cited by this paper
• A single sequence change destabilizes the influenza virus neuraminidase tetramer.

  1997cited by this paper
• Synergistic anti-influenza virus A (H1N1) activities of PM-523 (polyoxometalate) and ribavirin in vitro and in vivo

  1997cited by this paper
• Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en

  1996cited by this paper
• Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en

  1996cited by this paper
• Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme.

  1996cited by this paper
• Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en.

  1995cited by this paper
• Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en.

  1995cited by this paper
• Influenza: diagnosis, management, and prophylaxis

  1994cited by this paper
• Rational design of potent sialidase-based inhibitors of influenza virus replication

  1993cited by this paper
• Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase

  1993cited by this paper
• The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor

  1992cited by this paper
• Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

  1991cited by this paper
• Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection

  1988cited by this paper
• The molecular basis of the specific anti‐influenza action of amantadine.

  1985cited by this paper
• Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults

  1985cited by this paper
• Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics

  1983cited by this paper
• [2-Deoxy-2,3-dehydrosialic acids. II. Competitive inhibition of Vibrio cholerae neuraminidase by 2-deoxy-2,3-dehydro-N-acylneuraminic acids].

  1969cited by this paper
• Antiviral Activity of 1-Adamantanamine (Amantadine)

  1964cited by this paper
• Morbidity and Mortality Weekly Report Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (acip) Editorial and Production Staff Lead Technical Writer-editor Project Editor Recommendations for Using Antiviral Agents for Influenza . 24 Indications fo

  year unknowncited by this paper
• Resistant influenza A viruses in children treated with oseltamivir : descriptive study

  year unknowncited by this paper

• Integrated virtual screening and compound generation targeting H275Y mutation in the neuraminidase gene of oseltamivir-resistant influenza strains

  2025cites this paper
• Discovery of tetrasubstituted tetrahydropyrimidines as novel inhibitors against influenza a virus.

  2025cites this paper
• Molecular basis of influenza ribonucleoprotein complex assembly and processive RNA synthesis.

  2025cites this paper
• Optimization of the Monoclonal Antibody 3E1 through W32I Mutation Enhances Antiviral Efficacy against Influenza Virus Subtypes H1N1 and H3N2.

  2025cites this paper
• Triethylamine inhibits influenza A virus infection and growth via mechanisms independent of viral neuraminidase and RNA-dependent RNA polymerase

  2025cites this paper
• Phlorotannin-Rich Ascophyllum nodosum Seaweed Extract Inhibits Influenza Infection

  2024cites this paper
• Evolutionary Insights from Association Rule Mining of Co-Occurring Mutations in Influenza Hemagglutinin and Neuraminidase

  2024cites this paper
• Genetic and antigenic characterization of influenza A(H3N2) virus after 13 consecutive years of influenza surveillance in Senegal, 2010–2022

  2024cites this paper
• Bakuchiol targets mitochondrial proteins, prohibitins and voltage-dependent anion channels: New insights into developing antiviral agents

  2024cites this paper
• Influenza management with new therapies

  2023cites this paper
• Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants

  2023cites this paper
• Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy

  2023cites this paper
• Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study

  2023cites this paper
• Design, synthesis and structure-activity relationship of dihydrobenzoquinolines as novel inhibitors against influenza A virus.

  2022cites this paper
• Synthesis and anti-influenza virus activity evaluation of novel andrographolide derivatives

  2022cites this paper
• Novel β-Cyclodextrin-Based Heptavalent Glycyrrhetinic Acid Conjugates: Synthesis, Characterization, and Anti-Influenza Activity

  2022cites this paper
• Approaches for discovery of small-molecular antivirals targeting to influenza A virus PB2 subunit.

  2022cites this paper
• Mahuang Xixin Fuzi decoction protects the BALB/c-nude mice infected with influenza A virus by reducing inflammatory cytokines storm and weakly regulating SIgA immune response.

  2022cites this paper
• Nisoldipine Inhibits Influenza A Virus Infection by Interfering with Virus Internalization Process

  2022cites this paper
• Broad neutralizing antibody-based strategies to tackle influenza.

  2022cites this paper
• Synthesis and antiviral activity of a series of novel quinoline derivatives as anti-RSV or anti-IAV agents.

  2021cites this paper
• A novel aqueous extract from rice fermented with Aspergillus oryzae and Saccharomyces cerevisiae possesses an anti-influenza A virus activity

  2021cites this paper
• Organic synthesis and anti-influenza A virus activity of cyclobakuchiols A, B, C, and D

  2021cites this paper
• Comprehensive Profiling of Mutations to Influenza Virus PB2 That Confer Resistance to the Cap-Binding Inhibitor Pimodivir

  2021cites this paper
• Swine-origin influenza A (H1N1) virus: current status, threats, and challenges

  2021cites this paper
• Sequence dynamics of three influenza A virus strains grown in different MDCK cell lines, including those expressing different sialic acid receptors

  2021cites this paper
• Influenza A viruses serially passaged in different MDCK cell lines exhibit limited sequence variation across their genomes, with the exception of the hemagglutinin gene

  2020cites this paper
• Efficacy of anti-influenza immunoglobulin (FLU-IGIV) in ferrets and mice infected with 2009 pandemic influenza virus.

  2020cites this paper
• Influenza and antiviral resistance: an overview

  2020cites this paper
• Design, synthesis and anti-influenza A virus activity of novel 2,4-disubstituted quinazoline derivatives.

  2020cites this paper
• Synthesis, structure activity relationship and in vitro anti-influenza virus activity of novel polyphenol-pentacyclic triterpene conjugates.

  2019cites this paper
• Structural insight into RNA synthesis by influenza D polymerase

  2019cites this paper
• Influenza: A Unique Disease

  2019cites this paper
• Shikimic Acid: A Compound of Industrial Interest with Respect to Swine/Avian Flu

  2019cites this paper
• Evolutionary, genetic, structural characterization and its functional implications for the influenza A (H1N1) infection outbreak in India from 2009 to 2017

  2019cites this paper
• Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections

  2018cites this paper
• Surveillance for antiviral resistance among influenza viruses circulating in Algeria during five consecutive influenza seasons (2009‐2014)

  2018cites this paper
• An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin‐Bearing Influenza Viruses

  2017influential citation
• Synthesis and In Vitro Anti-Influenza Virus Evaluation of Novel Sialic Acid (C-5 and C-9)-Pentacyclic Triterpene Derivatives

  2017cites this paper
• Design, synthesis and biological evaluation of gentiopicroside derivatives as potential antiviral inhibitors.

  2017cites this paper
• A review of global human infection with avian influenza and epidemiological characteristics

  2017cites this paper
• Virological Surveillance of Influenza A Subtypes Isolated in 2014 from Clinical Outbreaks in Canadian Swine

  2017cites this paper
• Inhibition of influenza virus infection by multivalent pentacyclic triterpene-functionalized per-O-methylated cyclodextrin conjugates.

  2017cites this paper
• Design, synthesis and biological activity evaluation of novel conjugated sialic acid and pentacyclic triterpene derivatives as anti-influenza entry inhibitors

  2016cites this paper
• Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects

  2016cites this paper
• Intersubtype Reassortments of H5N1 Highly Pathogenic Avian Influenza Viruses Isolated from Quail

  2016cites this paper
• The inhibitory effect of dehydroepiandrosterone and its derivatives against influenza A virus in vitro and in vivo

  2016cites this paper
• Au nanoparticles for targeted photothermal destruction of influenza

  2015cites this paper
• genome comparison and characterization of avian H 10 viruses with different pathogenicity in Mink ( Mustela vison ) reveals genetic and functional differences in the non-structural gene

  2015cites this paper
• Refugee crisis demands European Union-wide surveillance!

  2015cites this paper
• Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses

  2015cites this paper
• Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.

  2015cites this paper
• Antiviral treatment of influenza in South Korea

  2015cites this paper
• Urgencias y emergencias

  2015cites this paper
• COMPARITIVE EVALUATION OF JATROPHA CURCAS LEAVES EXTRACT FOR ANTIBACTERIAL, ANTI-AVIAN INFLUENZA A VIRUS (H5N1) PROPERTIES AND GC-MS PROFILE

  2015cites this paper
• A protein chip based inhibitor screening for influenza neuraminidases: the importance of glycan-specific recognition

  2014cites this paper
• Production of functionally enhanced monoclonal antibodies via gene therapy

  2014cites this paper
• Phylogenetic analysis of neuraminidase gene of H9N2 avian influenza viruses isolated from chicken in Iran during 2010-2011

  2014cites this paper
• A Randomized Study of Standard versus Double dose Oseltamivir for Treating Influenza in the Community

  2014cites this paper
• A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade

  2014cites this paper
• Oseltamivir resistance among influenza viruses: surveillance in northern Viet Nam, 2009-2012.

  2013cites this paper
• Molecular distribution of amino acid substitutions on neuraminidase from the 2009 (H1N1) human influenza pandemic virus

  2013cites this paper
• Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy.

  2013cites this paper
• Nuevos métodos diagnósticos para la detección de virus respiratorios emergentes en población pediátrica

  2012cites this paper
• Exploring the Mechanism of Zanamivir Resistance in a Neuraminidase Mutant: A Molecular Dynamics Study

  2012cites this paper
• Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.

  2012cites this paper
• Pandemism of swine flu and its prospective drug therapy

  2012cites this paper
• Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses

  2012cites this paper
• Identification of Influenza Virus Inhibitors Targeting NS1A Utilizing Fluorescence Polarization–Based High-Throughput Assay

  2012cites this paper
• Tracking oseltamivir-resistance in New Zealand influenza viruses during a medicine reclassification in 2007, a resistant-virus importation in 2008 and the 2009 pandemic.

  2012cites this paper
• 2009H1N1 Influenza in Immunocompetent and Immunocompromised Patients

  2012cites this paper
• Update on Influenza Diagnostics: Lessons from the Novel H1N1 Influenza A Pandemic

  2012cites this paper
• Pandemic influenza A (H1N1) and other respiratory pathogens: clinical insights - from epidemiology to treatment

  2012cites this paper
• Molecular mechanisms of transcription and replication of the influenza A virus genome

  2011cites this paper
• Antivirals and resistance: influenza virus.

  2011cites this paper
• Systematic review of influenza resistance to the neuraminidase inhibitors

  2011influential citation
• Sequence analysis of the neuraminidase genes of avian influenza A viruses isolated from live bird markets in the United States

  2011cites this paper
• Inhibition of Influenza Virus Replication by Constrained Peptides Targeting Nucleoprotein

  2011cites this paper
• Assessing the Viral Fitness of Oseltamivir-Resistant Influenza Viruses in Ferrets, Using a Competitive-Mixtures Model

  2010cites this paper
• Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.

  2010cites this paper
• Molecular simulation study of the binding mechanism of [α-PTi2W10O40]7− for its promising broad-spectrum inhibitory activity to FluV-A neuraminidase

  2010cites this paper
• Development and implementation of influenza a virus subtyping and detection of genotypic resistance to neuraminidase inhibitors†

  2010cites this paper
• Targeting pandemic influenza: a primer on influenza antivirals and drug resistance.

  2010cites this paper
• Influenza, including the novel H1N1, in organ transplant patients

  2010cites this paper
• Structure-based mechanism of proton transport through the influenza A M2 protein

  2009cites this paper
• In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza Viruses

  2009cites this paper
• Anti-influenza therapy: The emerging challenge of resistance

  2009cites this paper
• Antiviral agents for influenza: molecular targets, concerns of resistance, and new treatment options.

  2009cites this paper
• Effective, Robust Design of Community Mitigation for Pandemic Influenza: A Systematic Examination of Proposed US Guidance

  2008cites this paper
• Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1).

  2008influential citation
• Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection

  2008cites this paper
• Influenza viruses with reduced sensitivity to the neuraminidase inhibitor drugs in untreated young children.

  2008cites this paper
• Genetic Strategy to Prevent Influenza Virus Infections in Animals

  2008cites this paper
• Neuraminidase inhibitor resistance in influenza viruses

  2007influential citation
• Fågelinfluensa (H5N1) - epidemilogi, klinik och antiviralbehandling Behandling och profylax av influensa med antivirala medel - Bakgrundsdokumentation

  2007cites this paper
• Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues.

  2007cites this paper
• marine drugs

  year unknowncites this paper
• Open Access Research

  year unknowncites this paper